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Abstract
Background: Between 1986 and 2008 Streptococcus pneumoniae was isolated from 41 pets/zoo animals (guinea pigs
(n=17), cats (n=12), horses (n=4), dogs (n=3), dolphins (n=2), rat (n=2), gorilla (n=1)) treated in medical veterinary
laboratories and zoos, and 44 laboratory animals (mastomys (multimammate mice; n=32), mice (n=6), rats (n=4), guinea
pigs (n=2)) during routine health monitoring in an animal facility. S. pneumoniae was isolated from nose, lung and
respiratory tract, eye, ear and other sites.
Methodology/Principal Findings: Carriage of the same isolate of S. pneumoniae over a period of up to 22 weeks was
shown for four mastomys. Forty-one animals showed disease symptoms. Pneumococcal isolates were characterized by
optochin sensitivity, bile solubility, DNA hybridization, pneumolysin PCR, serotyping and multilocus sequence typing.
Eighteen of the 32 mastomys isolates (56%) were optochin resistant, all other isolates were optochin susceptible. All
mastomys isolateswere serotype 14, allguinea pig isolatesserotype 19F, allhorse isolates serotype 3. Ratshad serotypes
14 or 19A, mice 33A or 33F. Dolphins had serotype 23F, the gorilla serotype 14. Cats and dogs had many different
serotypes. Four isolates were resistant to macrolides, three isolates also to clindamycin and tetracyclin. Mastomys
isolates were sequence type (ST) 15 (serotype 14), an ST/serotype combination commonly found in human isolates. Cats,
dogs, pet rats, gorilla and dolphins showed various human ST/serotype combinations. Lab rats and lab mice showed
single locus variants (SLV) of human STs, in human ST/serotype combinations. All guinea pig isolates showed the same
completely new combinationof known alleles. Thehorseisolates showed an unknownallelecombination and threenew
alleles.
Conclusions/Significance: The isolates found in mastomys, mice, rats, cats, dogs, gorilla and dolphins are most likely
identical to human pneumococcal isolates. Isolates from guinea pigs and horses appear to be specialized clones for these
animals. Our data redraw attention to the fact that pneumococci are not strictly human pathogens. Pet animals that live in
close contact to humans, especially children, can be infected by human isolates and also carriage of even resistant isolates is
a realistic possibility.
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Introduction
Streptococcus pneumoniae is the major causative pathogen of
community-acquired respiratory tract infections (RTIs) in humans,
including community-acquired pneumonia, acute otitis media and
acute maxillary sinusitis. It is also the cause of severe invasive
infections like meningitis and bacteremia in both children and
adults. Most humans, especially young children (0–5 years of age),
are likely to be colonized at least once during their lifetime with
pneumococci that are spread by droplet infection [1]. Pneumo-
coccal-related disease is usually preceded by colonization of the
nasopharynx. Therefore, pneumococcal carriage is believed to
play an important role in horizontal spread of S. pneumoniae in the
community.
In general, S. pneumoniae is considered to be a human pathogen
only, despite there being established mouse and rat models for
various S. pneumoniae-caused diseases [2]. For example, BALB/c
mice are used as models for pneumococcal pneumonia and
meningitis [3], and rats for pneumococcal otitis media [4].
Transmission of other streptococcal species from animals to
humans is well-documented, in particular for S. equi subsp.
zooepidemicus, S. canis, S. suis, S. porcinus and S. phocae [5,6,7,8,9].
Pneumococci are naturally competent organisms and can easily
exchange DNA in their natural habitat, the human mouth and
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which form a ‘gene pool’ out of which the pneumococci can
recruit their resistance genes. Gene transfer and mosaic genes have
been intensively reported for S. pneumoniae, S. oralis, S. sanguis and S.
mitis[10].
Multilocus sequence typing (MLST) produces unambiguous
molecular typing data [11,12]. The MLST technique is highly
portable as any laboratory can compare the sequences of the seven
loci in their isolates with those in a central database (www.mlst.net)
and thereby obtain the allelic profile of each isolate. MLST results
in data giving insight into the clonal relatedness of bacterial
isolates.
In the present study, we characterized a large collection of S.
pneumoniae from pets and laboratory animals including mastomys,
guinea pigs, cats, mice, rats, horses, dogs, dolphins and a gorilla.
Our findings show that S. pneumoniae is capable of colonizing and
infecting animal hosts and raises the question whether these
animals, which as pets are often in close contact to children, serve
as an extra-human reservoir for S. pneumoniae.
Results
During routine checks of animals in the animal facilities of the
German Cancer Research Center (DKFZ) in Heidelberg,
Germany, a-hemolysing streptococci were isolated from multi-
mammate mice (Mastomys coucha, n=32), rats (Rattus norwegicus
F344, n=4), mice (Mus musculus C57BL/6, n=6) and guinea pigs
(Cavia porcellus, n=2). Isolates from 41 pets comprising guinea pigs
(n=17), cats (Felis domesticus, n=12), dogs (Canis lupus familiaris,
n=3), horses (Equus caballus, n=4) and rats (Rattus rattus,n = 2 )
were received from a veterinary medical laboratory (Vet Med
Labor GmbH) in Ludwigsburg, Germany and the Department of
Infectious Diseases and Immunology (VMDC) of the Faculty of
Veterinary Medicine of the University of Utrecht, the Nether-
lands. Two isolates from dolphins (Tursiops truncatus) were obtained
from a zoo in Nuremberg, Germany and one isolate from a gorilla
(Gorilla gorilla) was from a zoo in Kerkrade, the Netherlands.
Two mastomys suffered from conjuntivitis. Two guinea pigs
(laboratory animals) were C4-immune deficient, and one of them
suffered from peritonitis and sepsis and died. All (n=17) pet
guinea pigs were obviously ill: RTI (n=10), otitis media (n=1),
abcesses (n=2), undefined illness (n=4). Both pet rats were ill (one
with RTI, one with unknown disease). Seven pet cats and three pet
dogs suffered from RTI. The five other pet cats suffered from otitis
media, otitis externa, conjunctivitis, polyarthritis and meningitis
respectively. The latter animal died. Three horses had RTI, for
one there were no detailed diagnostic data available. The two
dolphins were zoo animals that died without showing clear
symptoms of disease, but autopsy showed pneumococci in lung
biopsies. The gorilla suffered from acute infection with inflam-
mated tonsilli with purulent excretion.
Mastomys isolates were obtained from swabs taken from nose
(n=14), eye (n=10), nose and eye (n=2), lung (n=1) and trachea
(n=1). Carriage isolates were obtained from eye swabs. Guinea
pig isolates were from swabs from nose (n=10), ear (n=2) and
wound, abcess, lung, trachea, abdomen, bulla tympanica (one
each). For one animal the origin of the material could not be
traced anymore. Isolates from laboratory mice an rats were all
from nose swabs. For the two pet rats isolates wereobtained from
lung and wound swabs (one animal each). For the cats islates were
obtained from swabs from nose (n=5), thorax (n=2), and ear,
wound, throat, synovia (one animal each). For the cat that suffered
from meningitis and died the isolate was obtained from a brain
biopsy. The three dog isolates were obtained from nose swabs.
Horse isolates were obtained from nose swabs (n=3) and BAL
(n=1). The two isolates from dolphins were obtained from lung-
tissue biopsies. The gorilla isolate was obtained from purulent
secretion material (Table 1).
Further characterization of the streptococcal isolates at the
German National Reference Center for Streptococci confirmed
identification of all isolates as Streptococcus pneumoniae. All isolates
were bile soluble, showed hybridization with a species-specific
gene probe and had positive pneumolysin PCRs. Eighteen isolates,
all from mastomys, were optochin-resistant.
All mastomys isolates (n=32) were serotype 14. Guinea pig
isolates were 19F, mice isolates were 33A or 33F, laboratory rat
isolates were14, pet rat isolates were 19A, horse isolates were 3,
dolphin isolates were 23F and the gorilla isolate was 14. Cats
and dogs had a large variety of different serotypes (3 (n=2), 6A,
6B, 10A, 14 (n=2), 19A, 19F (n=3), 22A, 22F, 23F, 31)
(Table 1).
To exclude a possible transfer of S. pneumoniae from the animal
facility staff members to the laboratory animals, throat swabs of
animal facility staff members of the German Cancer Research
Center (DKFZ) were taken. None of the seven staff members were
found to carry pneumococci. All obtained isolates belonged to
normal throat flora (Streptococcus oralis, Streptococcus mitis, Streptococcus
parasanguis and Gemella morbillorum). No indications for the presence
of pathogenic species were found.
To determine whether mastomys could carry pneumococcal
isolates asymptomatically, four animals were followed over periods
of several weeks. S. pneumoniae could be isolated from the same
obviously healthy animal over periods of 6, 7, 17 and 22 weeks
respectively (Table 2). All isolates were serotype 14.
MIC analysis of the isolates showed that four isolates were
resistant to clarithromycin, three of them were also resistant to
clindamycin and tetracyclin. The isolates were from two cats and
two pet rats. The three multiresistant isolates showed an iMLSB
phenotype and an ermB genotype, the single resistant isolate had
the M-phenotype, and mef(A) subclass mef(A) (Table 3). All other
isolates were susceptible for all tested substances (penicillin G,
amoxicillin, cefotaxime, cefpodoxime, cefuroxime, clarithromycin,
clindamycin, tetracycline, levofloxacin, trimethoprim-sulfameth-
oxazole and vancomycin).
MLST analysis revealed that all mastomys isolates were
sequence type (ST)15. All 19 guinea pigs had STs with the same
new combination of existing alleles, which has not been found
previously, nor have single or double locus variants (Table 4).
Mice isolates showed two new sequence types, both single locus
variants (SLV) of ST100, one harbouring a variant spi allele, with
99% identity to allele 9, and the other a variant recP allele (99%
identity to allele 12). The four laboratory rats had the same SLV of
ST124, showing a variant gki allele (99% identity to allele 1). The
cats and dogs showed a large variety of STs (9, 124, 176, 177
(n=2), 180 (n=2), 311, 473, 819, 1815, 1994, 3017, 3705 and an
SLV of 1551). Three horses had the same new ST, with new alleles
for spi (99% identity to allele 10), xpt (99% identity to allele 1) and
ddl (99% identity to allele 6). The fourth horse (a pony horse) had
the same ST, except for the spi allele which was an exact match
with allele 10. Both dolphin isolates had ST 440, the gorilla isolate
ST 124 (Table 4).
ST 15/serotype 14, ST 100/33F, ST 124/14, ST 3546/19A
and ST 440/23F found in mastomys, mice, rats, dog, gorilla and
dolphins respectively are common sequence type/serotype com-
binations found in human pneumococcal isolates (www.mlst.net).
This is also the case for the combinations ST 9/14, ST 176/6B,
ST 177/19F, ST 180/3, ST 311/23F, ST 473/6A, ST 819/22F,
ST 1551/10A, ST 1815/19F, ST 1994/31, and ST 3017/19A
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Isolate
number Animal
Year of
isolation country origin Diagnosis
Site of
isolation
Opto
Test
Sero-
type MLST
24073 mastomys 1 2003 Germany DKFZ no clinical symptoms nose R 14 15
24074 mastomys 2 2003 Germany DKFZ no clinical symptoms nose S 14 15
24080 mastomys 3 2003 Germany DKFZ no clinical symptoms nose S 14 15
22877 mastomys 4 2003 Germany DKFZ no clinical symptoms nose R 14 15
22878 mastomys 5 2003 Germany DKFZ no clinical symptoms nose R 14 15
22879 mastomys 6 2003 Germany DKFZ no clinical symptoms trachea R 14 15
22875 mastomys 7 2004 Germany DKFZ no clinical symptoms nose R 14 15
22876 mastomys 8 2004 Germany DKFZ no clinical symptoms nose R 14 15
22881 mastomys 9 2004 Germany DKFZ no clinical symptoms nose R 14 15
22882 mastomys 10 2004 Germany DKFZ no clinical symptoms lung S 14 15
22883 mastomys 11 2004 Germany DKFZ no clinical symptoms nose R 14 15
22884 mastomys 12 2004 Germany DKFZ no clinical symptoms nose R 14 15
27110 mastomys 13 2005 Germany DKFZ no clinical symptoms nose S 14 15
22955 mastomys 14 2005 Germany DKFZ no clinical symptoms nose R 14 15
22956 mastomys 15 2005 Germany DKFZ no clinical symptoms nose R 14 15
26267 mastomys 16 2005 Germany DKFZ no clinical symptoms eye R 14 15
27072 mastomys 17 2006 Germany DKFZ no clinical symptoms nose/eye S 14 15
27673 mastomys 18 2006 Germany DKFZ no clinical symptoms eye R 14 15
27857 mastomys 19 2006 Germany DKFZ no clinical symptoms eye R 14 15
28293 mastomys 20 2006 Germany DKFZ no clinical symptoms nose/eye R 14 15
28417 mastomys 21 2006 Germany DKFZ no clinical symptoms eye R 14 15
28418 mastomys 22 2006 Germany DKFZ no clinical symptoms eye S 14 15
28419 mastomys 23 2006 Germany DKFZ no clinical symptoms eye R 14 15
28420 mastomys 24 2006 Germany DKFZ no clinical symptoms eye S 14 15
28421 mastomys 25 2006 Germany DKFZ no clinical symptoms eye S 14 15
28422 mastomys 26 2006 Germany DKFZ no clinical symptoms eye S 14 15
29791 mastomys 27 2006 Germany DKFZ conjunctivitis eye S 14 15
33432 mastomys 28 2008 Germany DKFZ conjunctivitis nose R 14 15
27703 mouse (C57BL/6) 1 2006 Germany DKFZ no clinical symptoms nose S 33A SLV100
28448 mouse (C57BL/6) 2 2006 Germany DKFZ no clinical symptoms nose S 33A SLV100
33645 mouse (C57BL/6) 3 2008 Germany DKFZ no clinical symptoms nose S 33F SLV100
32276 mouse (C57BL/6) 4 2007 Germany DKFZ no clinical symptoms nose S 33A SLV100
32969 mouse (C57BL/6) 5 2007 Germany DKFZ no clinical symptoms nose S 33A SLV100
32970 mouse (C57BL/6) 6 2007 Germany DKFZ no clinical symptoms nose S 33A SLV100
24072 rat (F344) 1 2003 Germany DKFZ no clinical symptoms nose S 14 SLV 124
24075 rat (F344) 2 2003 Germany DKFZ no clinical symptoms nose S 14 SLV 124
24077 rat (F344) 3 2003 Germany DKFZ no clinical symptoms nose S 14 SLV 124
24079 rat (F344) 4 2003 Germany DKFZ no clinical symptoms nose S 14 SLV 124
32965 rat 5 2007 Austria VML respiratory problems,
sudden death
lung S 19A 3546
34828 rat 6 2008 Monaco VML no data wound S 19A SLV
3546
24070 guinea pig 1 1986 Germany DKFZ peritonitis, sepsis lung S 19F new
24071 guinea pig 2 1986 Germany DKFZ peritonitis abdomen S 19F new
28614 guinea pig 3 2006 The
Netherlands
VML severe respiratory
problems
nose S 19F new
28976 guinea pig 4 2006 Germany VML head wound wound S 19F new
31598 guinea pig 5 2007 Germany VML umbillical abcess,
jaw abcess
abcess S 19F new
32066 guinea pig 6 2007 Germany VML respiratory problems,
clotted nose
nose S 19F new
Pneumococci from Animals
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number Animal
Year of
isolation country origin Diagnosis
Site of
isolation
Opto
Test
Sero-
type MLST
32449 guinea pig 7 2007 Germany VML purulent efflux nose, eyes nose S 19F new
32668 guinea pig 8 2007 Germany VML coughing, nasal discharge,
swollen lymphnodes
nose S 19F new
32669 guinea pig 9 2007 Germany VML coughing, nasal discharge nose S 19F new
33098 guinea pig 10 2007 France VML tired, tilted head ear S 19F new
33099 guinea pig 11 2007 Germany VML otitis media ear S 19F new
34603 guinea pig 12 2008 The
Netherlands
VML nasal discharge, tiredness nose S 19F new
34719 guinea pig 13 2008 Germany VML sneezing, nasal discharge nose S 19F new
34728 guinea pig 14 2008 Germany VML Abortion of offspring,
dead
Trachea,
uterus, liver
S 19F new
35456 guinea pig 15 2008 Peru VML no data nose S 19F new
34950 guinea pig 16 2008 Germany VML recidiving rhinitis nose S 19F new
35100 guinea pig 17 2008 Germany VML coughing, purulent
nasal discharge
nose S 19F new
35489 guinea pig 18 2006 The
Netherlands
VMDC no data no data S 19F new
35494 guinea pig 19 2007 The
Netherlands
VMDC respiratory problems bulla
tympanica
S 19F new
28615 cat 1 2006 The
Netherlands
VML severe respiratory
problems
nose S 3 180
31057 cat 2 2007 Germany VML otitis media wound S 19F 177
32317 cat 3 2007 Germany VML conjunctivitis, strong sniffing throat S 6A 473
32667 cat 4 2007 Germany VML rhinitis, conjunctivitis nose S 19F 1815
32827 cat 5 2007 Germany VML dyspnoea, lungoedema, thorax
puncture
S 22F 819
33211 cat 6 2008 Germany VML purulent otitis externa ear S 14 9
34829 cat 7 2008 Deutschland VML nasal efflux nose S 31 1994
35135 cat 8 2008 The Netherlands VML sneezing, nasal discharge nose S 19A 3017
35488 cat 9 2003 The Netherlands VMDC purulent meningitis, died brain S 23F 311
35490 cat 10 2003 The Netherlands VMDC chronic rhinitis nose S 6B 176
35492 cat 11 1997 The Netherlands VMDC polyarthritis synovia S 22A 3705
35493 cat 12 2004 The Netherlands VMDC liquothorax, respiratory
problems
thorax fluid S 19F 177
32966 dog 1 2007 Netherlands VML coughing, sneezing, nasal
discharge
nose S 14 124
33437 dog 2 2008 Germany VML chronic recidivating
rhinitis
nose S 3 180
33770 dog 3 2008 Germany VML sinusitis nose S 10A SLV1551
29800 horse 1 2006 Germany VML sinusitis nose S 3 new
32450 horse 2 (pony) 2007 Germany VML coughing, nasal discharge nose S 3 new
34368 horse 3 2008 Germany VML no data nose, trache-
allavage
S3n e w
34604 horse 4
(racing horse)
2008 Germany VML coughing, nasal discharge,
swollen lymphnodes
BAL S 3 new
24186 dolphin 1 1986 Germany ZN died withour disease
symptoms
biopsy lung S 23F 440
24187 dolphin 2 1986 Germany ZN died withour disease
symptoms
biopsy lung S 23F 440
35491 ape (gorilla) 2008 The Netherlands ZK acute infection, inflammated
tonsilli with pus excretion
pus S 14 124
aDKFZ: German Cancer Research Center (DKFZ), Heidelberg, Germany; VML: Vet Med Labor GmbH, Ludwigsburg, Germany, VMDC: Department of Infectious Diseases
and Immunology (VMDC) of the Faculty of Veterinary Medicine of the University of Utrecht, the Netherlands, ZN: Zoo Nuremberg, Germany, ZK: Zoo Kerkrade, The
Netherlands.
doi:10.1371/journal.pone.0008286.t001
Table 1. Cont.
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one cat has so far never been encountered in humans.
Discussion
It is generally accepted that Streptococcus pneumoniae is strictly a
human pathogen despite there being animal models (mouse, rat)
available to study pneumococcal infections. However, on the other
hand, recent literature describing naturally occurring carriage of
or infections by pneumococci in animal hosts is scarce [13,14]. A
report from 1988 describes the isolation of S. pneumoniae serotype 3
from a racehorse [15]. Other pneumococcal isolates from
racehorses also appear to have serotype 3 [16,17]. In a recent
report from Chi et al. S. pneumoniae isolated from Chimpansees are
described [13]. Notably, anecdotal reports of S. pneumoniae isolated
from animals can be found as early as in the 1940s (Table 5).
Outbreaks of infections with S. pneumoniae of serotypes 2, 3, 8
and 19 in laboratory rats in the US have been described in several
publications [18,19,20,21]. Furthermore, veterinary textbooks
describe pneumococcal infections to be not only present in
rodents (rats, mice, guinea pigs) but also in larger domestic animals
(calves, horses) [22,23].
Since all pneumococcal isolates obtained from animals in this
study were bile soluble, and showed hybridization with a species
specific DNA probe, they were unambiguously identified as S.
pneumoniae. Moreover, the fact that serotyping and MLS typing
gave positive results confirms that the isolates are pneumococci.
However, 18 out of 32 mastomys isolates were optochin-resistant.
Since pneumococcal isolates are almost always optochin suscep-
tible and optochin resistance is usually a trait of other viridance
group streptococci, this could be one of the reasons why
pneumococci are being overlooked and therefore not reported in
animal isolates, thereby leading to underrepresentation of
information on the extent of pneumococci colonization in the
literature. Finally, it is noteworthy that optochin-resistant
pneumococci are being increasingly reported from human sources
[24].
The most obvious cause of infection for the laboratory animals
would be the animal facility staff. For the mastomys colony in the
German Cancer Research Center this could be verified. None of
the staff carried pneumococci at the moment of sampling, making
it less likely that animals had been infected recently. However, it
cannot be excluded that the colony got infected at an earlier point
in time since carriage in humans is transient. For the other
laboratory animals, which came from large commercial facilities, a
possible infection by facility staff members could not be tested.
Most ST/serotype combinations identified in the isolates in this
study are commonly found among human pneumococcal isolates
(www.mlst.net). The combination ST 15/serotype 14, found in 28
mastomys is commonly found among human isolates in association
with meningitis and bacteremia and has been reported from the
UK, the Netherlands, Portugal, Germany, Italy, Brazil and Hong
Kong (www.mlst.net).
The combination ST 100/33F is commonly encountered
among human isolates and has been reported from Spain,
Germany, Poland and USA. The combination with serotype
33A has not been reported so far (www.mlst.net). This could
indicate that a serotype switch from 33F to 33A has occurred in
mice, as well as a mutation in the spi or the recP allele.
The combination ST 124/serotype 14 found in the gorilla, a
dog and, as an SLV, in the laboratory rats has been reported from
Germany, Sweden, UK, Denmark, Finland, Norway, The
Netherlands, Australia, Canada, and Poland and is associated
with meningitis, bacteremia, pneumonia and otitis media in
human isolates, as well as with carriage (www.mlst.net).
The combination ST 3546/19A found in two pet rats has been
reported only once, from Norway, and was isolated from blood
(www.mlst.net).
Table 2. Carriage of S. pneumoniae by mastomys.
Isolate
number Animal
1st sample
(week
of life)
last
sample
(week of
life)
Carriage
length
(weeks)
Year of
isolation country origin Diagnosis
Site of
isolation
Opto
Test Serotype MLST
31578 mastomys #18 52 74 22 2007 Germany DKFZ no clinical symptoms eye S 14 n.d.
32161 mastomys #29 66 73 7 2007 Germany DKFZ no clinical symptoms eye S 14 n.d.
31467 mastomys #33 55 72 17 2007 Germany DKFZ no clinical symptoms eye S 14 n.d.
31580 mastomys #168 45 51 6 2007 Germany DKFZ no clinical symptoms eye S 14 n.d.
aDKFZ: German Cancer Research Center (DKFZ), Heidelberg, Germany; n.d.: not done.
doi:10.1371/journal.pone.0008286.t002
Table 3. Macrolide resistant isolates found in pet cats and rats.
Animal Diagnosis MLST Serotype
Macrolide
resistance
genotype
Macrolide
resistance
phenotype
CLA (mg/
ml)
CLI (mg/
ml)
TET (mg/
ml)
PEN (mg/
ml)
CEF (mg/
ml)
cat 4 rhinitis, conjunctivitis 1815 19F ermB iMLSB 16 16 16 0,015 0,015
cat 6 otitis externa eitrig 9 14 mefA M 8 0,12 0,25 0,015 0,015
rat 5 Breathing problems, sudden death 3546 19A ermB iMLSB 16 8 16 0,015 0,015
rat 6 no data SLV 3546 19A ermB iMLSB 16 16 16 0,06 0,015
CLA: clarithromycin, CLI: clindamycin, TET: tetracyclin, PEN: penicillin, CEF: cefotaxime.
doi:10.1371/journal.pone.0008286.t003
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Republic, Switzerland) found in the two dolphins is also commonly
encountered among human isolates where it is associated with
meningitis and bacteremia as well as being found in carriage
(www.mlst.net).
The combination ST 180/serotype 3 found in a cat and in a
dog isolate has been reported from several countries (UK, Spain,
Poland, Portugal, Italy, Taiwan, Canada, Denmark, Netherlands)
and is associated with invasive disease (meningitis, bacteremia) but
also with community acquired pneumonia, otitis media and
Table 4. MLSTs of 81 Streptococcus pneumoniae isolates from pets and laboratory animals in Germany.
Animal
number of
animals Year Serotype MLST aroE gdh gki recP spi xpt ddl
mastomys 28 2003–2006 14 15 1 5 4 5 5 3 8
guinea pig 19 1986/2006/
2007/2008
19F new 2 5 4 5 27 20 5
mouse (C57BL/6) 5 2006 33A/33F new (SLV 100) 5 12 29 12 9 (99%) 39 18
mouse (C57BL/6) 1 2006 33A new (SLV 100) 5 12 29 12 (99%) 9 39 18
rat (F344) 4 2003 14 new (SLV 124) 7 5 1 (99%) 8 14 11 14
rat (pet) 1 2007 19A 3546 1 5 41 5 10 28 8
rat (pet) 1 2008 19A new (SLV 3546) 1 5 41 5 10 99% 28 8
cat 1 2008 14 9 1 5 4 5 5 1 8
cat 1 2003 6B 176 7 13 8 6 10 6 14
cat 2 2004/2007 19F 177 7 14 4 12 1 1 14
cat 1 2006 3 180 7 15 2 10 6 1 22
cat 1 2003 23F 311 1 8 9 1 6 4 6
cat 1 2007 6A 473 7 25 4 4 15 20 28
cat 1 2007 22F 819 1 1 4 1 18 58 18
cat 1 2007 19F 1815 1 5 4 12 5 3 159
cat 1 2008 31 1994 1 2 29 1 111 14 18
cat 1 2008 19A 3017 8 11 14 1 17 230 14
cat 1 1997 22A 3705 2 194 53 18 10 1 1
dog 1 2007 14 124 7 5 1 8 14 11 14
dog 1 2008 3 180 7 15 2 10 6 1 22
dog 1 2008 10A SLV 1551 5 7 4 6 10 1 6
horse 3 2006 3 new 10 9 4 12 10 (99%) 10 (99%) 6 (99%)
horse (pony) 1 2007 3 new 10 9 4 12 10 10 (99%) 6 (99%)
dolphin 2 1986 23F 440 7 5 1 1 13 31 14
gorilla 1 2008 14 124 7 5 1 8 14 11 14
doi:10.1371/journal.pone.0008286.t004
Table 5. Anecdotal reports of Streptococcus pneumoniae isolated from different mammalian species.
Animals
Number of
infected animals Outbreak Serotypes
Laboratory
animals Year Source
guinea pigs 39 yes 19 yes 1945 Homburger et al. [33]
rats 71 yes 2 yes 1950 Mirick et al. [18]
rats 254 yes 8 yes 1965 Ford [19]
rats 156 no 2, 3, 19 yes 1969 Weisbroth and Freimer [20]
rats 32 no 3 yes 1971 Mitruka [21]
mice, rats 9,10 yes 35 yes 1988 Fallon et al. [34]
horses 10 no 3 no 1988 Huber and Willoughby [15]
horses 11 no 3 no 1999 Whatmore et al. [16]
cat 1 no n.d. no 2006 Zhang et al. [14]
n.d: no data.
doi:10.1371/journal.pone.0008286.t005
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ST 177/19F, ST 311/23F, ST 473/6A, ST 819/22F, ST 1551/
10A, and ST 1994/31 found in cats and dogs are all well known
human ST/serotype combinations associated with both invasive
disease and carriage (www.mlst.net). Two isolates, ST 1815/19F
and ST 3017/19A, both found in cats have been reported only
once to the MLST database (www.mlst.net). ST 1815/19F was
from a case of bacteremia from the Czech Republic. ST 3017/
19A was isolated from blood from a patient from the Netherlands,
which is also the country of origin of the cat. The combination ST
3705/22A has not been reported to the MLST database. The only
isolate with ST 3705 is a carriage isolate from the Netherlands
with serogroup 19. Again this isolate is from the same country as
the cat in this study.
eBURST analyses revealed that STs 15, 124, 177, 180, 473
and 1994 are all predicted founders of clonal complexes (CC).
ST 124 is the predicted founder of a group of 78 STs and is one
of the original penicillin-resistant clones described in South
Africa [25]. CC124 also comprises ST 440. ST9 and ST1815
belong to CC15. STs 176, 311, 819, 1551, and 3705 are
members of different clonal complexes. STs 3546 and 3017 are
singletons, i.e. they are not related to any other STs in the
database. Taken together, our data show that the pneumococcal
isolates from mastomys, mice, rats, cats, dogs, dolphins and
gorilla analysed in this study are highly similar, if not identical,
to human isolates related to invasive pneumococcal disease and
carriage.
Serotype 19F, found in all four guinea pig isolates, is a common
serotype found in human isolates (www.mlst.net), where it is
associated with invasive pneumococcal disease as well as carriage.
It occurs in combination with large numbers of different STs.
However, the STs of all 19 guinea pig isolates consist of a new
allele combination never encountered in human isolates. From
these findings it may be interpreted that the guinea pigs did not
pick up the pneumococcal infections from humans. Moreover, the
fact that the same new allele combination has been found in
isolates from guinea pigs from different locations (pets, laboratory
animals), different countries (France, Germany, Peru, the Nether-
lands) and widely separated in time (1986, 2006) seems to indicate
that this clone is typical for guinea pigs and that these animals are
a reservoir for S. pneumoniae of this specific sequence type. As
apparent from our diagnostic data, this clone is clearly pathogenic
for guinea pigs.
The four horse isolates described here have serotype 3 and a
new ST, with three or two new alleles. Whatmore et al. report on a
collection of horse pneumococcal isolates of serotype 3 and
conclude on the basis of RFLP analyses that these isolates are
closely related to, but distinguishable from human pneumococcal
isolates [16]. Showing a new sequence type, our data confirm that
the horse isolates form a population different from human isolates.
Pneumococci found in guinea pigs and horses seem to belong to
separate host specific populations. The isolates found in mastomys,
mice, rats, cats, dogs, dolphins and gorilla are most likely identical
to human pneumococcal isolates.
Four animals, two cats and two rats, had macrolide resistant
isolates. One cat isolate showed moderate resistance to clarithro-
mycin and carried the mefA subclass mef(A) gene. The isolate had
ST15 combined with serotype 14, which is the most common
macrolide resistant clone (PMEN England
14-9) in Germany
[26,27]. The other isolates all contained the ermB resistance
marker, which results in higher MICs for clarithromycin and
resistance to clindamycin. These isolates were also resistant to
tetracyclin. The ST/serotype combinations were 1815/19F
and (SLV)3546/19A. As discussed above these are rather rare
combinations. However, serotypes 19A and 19F are strongly
associated with multidrug resistance.
Our findings are unequivocal proof that pneumococci are
capable of causing severe disease in a number of different animal
species. One of the pet guinea pigs was a member of a larger
colony in which the animals suffered from respiratory problems
and of which several animals died. Further, the cats, dogs and
horses also suffered from severe respiratory problems, and the two
dolphins were likely to have died from pneumococcal infections.
On the other hand, laboratory animals (mastomys, mice and
rats) from which pneumococci were isolated showed no disease
symptoms. For two animals from the mastomys colony that
suffered from conjunctivitis, another potential causative agent for
the clinical signs (Pasteurella pneumotropica biotype Heyl) was found
in large numbers in addition to S. pneumoniae. This finding indicates
that the rodents may carry S. pneumoniae in their normal flora
without suffering from pneumococcal disease, much like in the
case of humans. Indeed, for four individual mastomys, we were
able to isolate the same isolate over a period of up to 22 weeks,
showing that the animals are carriers.
This is the first time that a larger collection of S. pneumoniae
isolated from a range of animals has been characterized on a
molecular basis using MLST, enabling a solid comparison to
human isolates present in the MLST database. The results show
that on one hand animals can be infected with human
pneumococcal clones. On the other hand animals like horses
and guinea pigs seem to be affected by their ‘own’ specific
pneumococcal clones. The fact that pets like cats, dogs, guinea
pigs, rats and mice are possible carriers of pneumococcal strains,
and in many cases of the same ST/serotype combinations as
human isolates, is worrisome. Even more alarming is the fact that
antibiotic resistant strains, on one occasion even the most common
macrolide resistant clone in Germany (England
14-9), could be
isolated from pets. Our data imply that there is an infection route
for pneumococci from humans to pet animals that live in close
contact to humans, especially children. By residing in animals,
pneumococci would not only enlarge their gene-pool with other
streptococcal species found more commonly in animals, but would
also be able to avoid the negative selective pressure of vaccination
in children. The question remains if pneumococci residing in
animals can re-infect humans. On basis of the present data no
conclusion on this can be drawn and further research is needed.
Materials and Methods
Study material
The German National Reference Center for Streptococci
(GNRCS) received a total of 85 bacterial isolates from animals
in Austria, France, Germany, Monaco, The Netherlands and Peru
in 1986 (n=4) and during 2003–2008 (n=81). Fourty-four isolates
were from the animal facility of the German Cancer Research
Center (DKFZ) in Heidelberg, Germany, 32 isolates were from
pets treated at a commercial veterinary medical laboratory (Vet
Med Labor GmbH) in Ludwigsburg, Germany, 6 isolates were
obtained from the Department of Infectious Diseases and
Immunology (VMDC) of the Faculty of Veterinary Medicine of
the University of Utrecht, the Netherlands, two isolates were from
a zoo in Nuremberg and one from a zoo in Kerkrade, the
Netherlands. All samples were sent to the GNRCS as isolated
bacteria, no primary material was received.
Testing of animal facility staff
Throat swaps were obtained in May 2006 from seven members
of the animal facility staff of the German Cancer Research Center
Pneumococci from Animals
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methods. Throat swabs were taken by the institute medical officer
of the DKFZ, after verbal consent of each of the animal facility
staff members. Isolated bacteria were analysed both at the DKFZ
as well as at the GNRCS.
Characterization of isolates
Streptococcus pneumoniae isolates were characterized by optochin
susceptibility and bile solubility testing. Optochin susceptibility
testing was carried out in a 5% CO2 atmosphere on sheep blood
agar [28]. Bile solubility testing was performed by preparing a
bacterial suspension in 1 mL 0.85% NaCl (McFarland standard
1.0) adding four drops of 10% sodium deoxycholate. Complete
lysis after incubation for 2 h at 35uC was taken as a positive
result. A commercially available DNA hybridization test
(AccuProbeH Streptococcus pneumoniae identification test; bioMe ´r-
ieux, Germany) was used according to the manufacturer’s
instructions.
Serotyping
Pneumococcal strains were serotyped by the Neufeld Quellung
reaction using type and factor sera provided by the Statens Serum
Institut, Copenhagen, Denmark [29].
Susceptibility testing
Minimal inhibitory concentration (MIC) testing was performed
using the broth microdilution method as recommended by the
Clinical Laboratory Standards Institute [30]. Microtiter plates
containing penicillin G, amoxicillin, cefotaxime, cefpodoxime,
cefuroxime, clarithromycin, clindamycin, tetracycline, levofloxa-
cin, trimethoprim-sulfamethoxazole and vancomycin with cation-
adjusted Mueller-Hinton broth (Oxoid, Wesel, Germany) plus 5%
lysed horse blood (Oxoid) were used. The final inocculum was
5610
5 CFU/ml. MICs were determined following incubation for
24 h at 35uC in ambient air. S. pneumoniae ATCC 49619 was used
as a control strain. Current Clinical Laboratory Standards
Institute interpretive criteria were used to define antimicrobial
resistance [30].
DNA extraction
Isolates were inoculated from agar plates (5% sheep blood) into
a sterile culture tube containing 10 mL Todd-Hewitt broth (Oxoid
Limited Basingstoke, Hampshire, UK) and incubated over night at
37uC. After centrifugation, the chromosomal DNA was isolated
using a DNA extraction kit (Qiagen, Hilden, Germany).
Pneumolysin PCR
Analysis of the pneumolysin gene (ply) was performed using real-
time PCR on a Light Cycler (Roche Diagnostics GmbH, Penzberg,
Germany) according to the LightCycler Operator’s Manual
Version 3.5. PCR was carried out using the Light Cycler Faststart
DNA Master SYBR Green I – kit according to the manufacturer’s
instructions. The reaction mixture of 20 ml contained 2 ml SYBR
Green I, 2 ml MgCl2,1 2mlH 20, 1.5 ml of each primer and 200 ng
of DNA. The oligonucleotide primers pair was ply
fwd 894–915 59
TGC AGA GCG TCC TTT GGT CTA T 39 and ply
rev 974–950
59 CTC TTA CTC GTG GTT TCC AAC TTG A 39 [31]. PCR
cycling comprised initial denaturation for 10 min at 95uC and 35
amplification cycles for 0 s at 95uC, 2 s at 62uC and 4 s at 72uC
with temperature transition rates of 20uC/s. This was followed by
a melting programme of 30 s at 95uC, 30 s at 67uC and 0 s at
95uC at rates of 20, 20, and 0.1uC/s, respectively, and cooling at
40uC for at least 30 s.
Multilocus sequence typing
Multilocus sequence typing (MLST) of 81 isolates was carried
out as described previously. Briefly, internal fragments of the aroE,
gdh, gki, recP, spi, xpt and ddl genes were amplified by PCR from
chromosomal DNA with the primer pairs described by Enright
and Spratt [12]. The alleles at each of the seven loci provide the
allelic profile of each isolate and also define their sequence type
(ST). Allelic profiles are shown as the alleles at each of the seven
loci, in the order aroE, gdh, gki, recP, spi, xpt and ddl.
MLST analysis
STs were compared to the pneumococcal MLST database on
www.mlst.net. The STs were analysed using the program
eBURST. This program is able to predict and display the
relationships between closely-related isolates of a bacterial species
or population. eBURST, unlike cluster diagrams, trees or
dendrograms, uses a simple but appropriate model of bacterial
evolution in which an ancestral (or founding) genotype increases in
frequency in the population, and while doing so, begins to diversify
to produce a cluster of closely-related genotypes that are all
descended from the founding genotype. This cluster of related
genotypes is referred to as a ‘clonal complex’ (eburst.mlst.net) [32].
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